Is Enovix an Underrated Small Cap?
Enovix (NASDAQ:ENVX) is one of several small, innovative companies hoping…
Sell
40
BEAM Quote, Financials, Valuation and Earnings
Last price:
$17.41
Seasonality move
:
31.21%
Day range:
$17.37 - $18.75
52-week range:
$13.53 - $35.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
22.97x
P/B ratio:
1.56x
Volume:
2.4M
Avg. volume:
2.8M
1-year change:
-22.76%
Market cap:
$1.8B
Revenue:
$63.5M
EPS (TTM):
-$4.61
Beam Therapeutics SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
BEAM
Beam Therapeutics
|
11/08/2023 | 10-Q | 10-Q filing on 11/08/2023 | View Form |
|
BEAM
Beam Therapeutics
|
08/08/2023 | 10-Q | 10-Q filing on 08/08/2023 | View Form |
|
BEAM
Beam Therapeutics
|
05/10/2023 | 10-Q | 10-Q filing on 05/10/2023 | View Form |
|
BEAM
Beam Therapeutics
|
11/07/2022 | 10-Q | 10-Q filing on 11/07/2022 | View Form |
|
BEAM
Beam Therapeutics
|
08/09/2022 | 10-Q | 10-Q filing on 08/09/2022 | View Form |
|
BEAM
Beam Therapeutics
|
05/09/2022 | 10-Q | 10-Q filing on 05/09/2022 | View Form |
|
BEAM
Beam Therapeutics
|
11/08/2021 | 10-Q | 10-Q filing on 11/08/2021 | View Form |
|
BEAM
Beam Therapeutics
|
08/10/2021 | 10-Q | 10-Q filing on 08/10/2021 | View Form |
|
BEAM
Beam Therapeutics
|
05/11/2021 | 10-Q | 10-Q filing on 05/11/2021 | View Form |
|
BEAM
Beam Therapeutics
|
11/10/2020 | 10-Q | 10-Q filing on 11/10/2020 | View Form |
|
BEAM
Beam Therapeutics
|
08/12/2020 | 10-Q | 10-Q filing on 08/12/2020 | View Form |
|
BEAM
Beam Therapeutics
|
05/12/2020 | 10-Q | 10-Q filing on 05/12/2020 | View Form |
|
BEAM
Beam Therapeutics
|
03/30/2020 | 10-K | 10-K filing on 03/30/2020 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Are We Heading Toward a Recession?
Fears of a recession in 2025 grew at the end…
3 Recession-Proof ETFs to Invest in Now
The U.S. gross domestic product (GDP) contracted 0.3% during the…
Stock Ideas
Buy
68
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Sell
39
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
61
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 40x
Alerts
Buy
60
RGC alert for May 10
Regencell Bioscience Holdings [RGC] is up 79.25% over the past day.
Buy
97
NGVC alert for May 10
Natural Grocers by Vitamin Cottage [NGVC] is up 30.26% over the past day.
Sell
38
ONTO alert for May 10
Onto Innovation [ONTO] is down 30.17% over the past day.
